All In MedTech

Device Trial Radar · NCT03806881

Long Term Follow-up After Primary or Revision Shoulder Arthroplasty With a Patient- Specific Glenius Implant

Long Term Follow-up After Primary or Revision Shoulder Arthroplasty With a Patient- Specific Glenius Implant: A Prospective Cohort Study

Last checked: Nov 19, 2026Latest source record: Oct 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

24

Planned (sponsor's estimate)

Start

Jul 1, 2019

Primary completion

Mar 2030

Study completion Mar 2030

Sponsor

Lead sponsor
MaterialiseNot on our public-company list
Sponsor type
Industry
First posted
Jan 16, 2019

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This post-market follow-up study investigates improvement in clinical and radiological outcome after reversed total shoulder arthroplasty with the patient-specific Glenius Glenoid Reconstruction system

Conditions

  • Arthroplasty, Replacement, Shoulder
  • Glenoid Cavity
  • Osteoarthritis of the Shoulder

Interventions

  • reversed glenoid prothesisDevice

    All patients will undergo a primary or revision arthroplasty with Glenius according to the routine practice at the investigation site and will be followed at specified visiting moments, during which radiological and clinical data will be gathered.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in baseline Constant-Murley Score after surgeryTime frame: 6 weeks, 3 months, 1 year, 2 year, 5 years after surgery

Locations

4 sites in 2 countries. Site status is shown where the registry gives one.

  • AZ St-Elisabeth

    Herentals, Belgium

  • University Hospital Leuven - Traumatology

    Leuven, Belgium

  • University Hospital Leuven - Orthopedics

    Leuven, Belgium

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.